iStent Infinite

DEVICE3 trials

Sponsors

Glaukos Corporation

Conditions

GlaucomaGlaucoma, Open-Angle

Phase 4

Travoprost Intraocular Implant + iStent Infinite

RecruitingNCT06066645

Glaukos CorporationGlaucoma, Open-Angle

Start: 2023-09-14End: 2028-02-01Target: 150Updated: 2026-06-02

Unknown Phase

Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor

Active, not recruitingNCT05127551

Glaukos CorporationGlaucoma, Glaucoma, Open-Angle

Start: 2021-11-27End: 2025-02-28Updated: 2024-08-15

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

RecruitingNCT06057051

Glaukos CorporationGlaucoma

Start: 2023-09-01End: 2027-08-31Target: 245Updated: 2023-09-28

Related Papers

Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY Study.

2025-03-253 citations